Home Infusion Therapy Market Forecast: USD 45.28 Billion in 2024 to USD 77.34 Billion by 2033 at 6.13% CAGR

Home Infusion Therapy Market Analysis

The home infusion therapy market is expected to grow at a compound annual growth rate (CAGR) of 6.13% from 2025 to 2033. This growth will increase the market size from approximately USD 45.28 billion in 2024 to USD 77.34 billion by 2033. Several factors are driving the demand for home infusion therapy, including the rising incidence of chronic illnesses, an aging population, advancements in healthcare technology, an increasing preference for at-home care, cost-effectiveness, and improved patient outcomes associated with home-based therapies.

Access full report: https://www.renub.com/home-infusion-therapy-market-p.php

Global Home Infusion Therapy Market Overview

Home infusion therapy involves administering medication or fluids through an IV in a patient's home instead of in a hospital or other healthcare facility. This medical treatment is typically prescribed for patients who require long-term or frequent intravenous therapies for conditions such as cancer, infections, immune disorders, and other chronic diseases. Home infusion therapy offers patients a convenient and cost-effective alternative to hospital or clinic-based treatment, as it reduces the need for hospital stays and associated costs.

The Home Infusion Therapy Market has been rapidly growing in recent years due to several factors. One of the main drivers is the increasing prevalence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases. These conditions often necessitate long-term medication treatment, which can be effectively administered through home infusion therapy.

Key information covered in the report

• Base Year - 2024
• Historical Period - 2021-2024
• Market Forecast - 2025-2033
• Market - US$ Billion

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=home-infusion-therapy-market-p.php

According to the 2023 Home Care Chartbook from the Research Institute for Home Care (RIHC), there were 11,353 active home health agencies in the U.S. as of 2022. This number decreased from 11,474 in 2021, 11,565 in 2020, and 11,569 in 2019. Additionally, the Centers for Medicare & Medicaid Services (CMS) classify home health services under the Medicare benefit program. Home infusion therapy is defined as a process in which patients receive biologics and medications at home. This also includes nursing services that provide training and education to patients on the safe intravenous administration of these drugs.

The market's expansion is also significantly influenced by technological developments. Innovations like portable infusion pumps and electronic health records are making home infusion therapy more convenient and efficient for both patients and healthcare providers. Portable infusion pumps are small, battery-operated devices that allow patients to receive their medication or fluids without being confined to a stationary pump. Meanwhile, electronic health records enhance communication between healthcare providers, ensuring that patients receive appropriate treatment.

Cost-effectiveness is another important factor driving the Home Infusion Therapy Market. Home infusion therapy can be less expensive than hospital or facility-based treatments, as it minimizes hospital stays and their associated costs. Additionally, patients save on transportation expenses since healthcare providers typically visit patients at home to administer medication.

The market for home infusion therapy is expanding as a result of the aging population. The need for home infusion therapy and other healthcare services is growing as the population ages because older people frequently have more complicated medical demands that need for continuous care.

Home Infusion Therapy Market Trends

Integration of Digital Health Tools

Digital health tools are being used into home infusion therapy to improve patient monitoring and facilitate real-time data sharing between patients and healthcare professionals. These systems improve remote care management by providing insights into therapy progress, thus enhancing adherence and allowing for adjustments to treatment plans while minimizing the need for in-person consultations. For example, in May 2024, Moog received U.S. FDA approval for its Dose IQ Safety Software and Novum IQ big volume infusion pump, specifically designed for home infusion therapy. This system facilitates precise multi-therapy infusions, features an intuitive user interface, and integrates with CURLIN RxManager, thereby enhancing safety and control for home care pharmacists and patients.

Growing Demand for Specialized Infusion Services

The demand for specialized infusion services has increased as more patients require complex treatments for chronic conditions. These services provide tailored therapies delivered in a home setting, thus reducing the need for hospital visits. This personalized approach effectively manages long-term illnesses while improving patient comfort and treatment outcomes. For instance, in February 2024, Dynamic Access launched Dynamic Infusion, a specialty home infusion nursing provider that caters to patients with chronic conditions such as autoimmune disorders and multiple sclerosis. They have partnered with over 35 specialty pharmacies to offer more than 10,000 home visits annually across nine states, enhancing patient care significantly.

Increasing Adoption of Advanced Infusion Technology

Technological advancements are transforming home infusion therapy by introducing smart infusion pumps and safety software that improve precision, safety, and efficiency. These innovations help reduce medication errors, enhance patient monitoring, and provide seamless integration with digital systems, ultimately streamlining home-based care and alleviating the burden on caregivers. For example, in April 2024, Baxter received U.S. FDA clearance for its Novum IQ large volume infusion pump and Dose IQ Safety Software. This development enhances home infusion therapy by offering integrated smart pump solutions that boost patient safety and operational efficiency, while also addressing the challenges faced by clinicians and advancing connected care.

Get Customization in the Report: https://www.renub.com/request-customization-page.php?gturl=home-infusion-therapy-market-p.php

Restraining Factors

Limited Reimbursement for Home Care Hinders Market Growth

One of the major factors likely to impede market growth is the lack of reimbursement policies in many developing nations. In home infusion therapy, reimbursement rates can vary significantly depending on the therapy provided and the medical indication. In countries like India and China, out-of-pocket healthcare expenses are higher than in nations with established reimbursement systems. The absence of reimbursement policies for home care in these regions exacerbates the situation.

Consequently, the number of patients in underdeveloped nations undergoing home infusion therapy has been limited. Additionally, the limited number of public and private home infusion service providers, the shortage of trained medical personnel, and other resource limitations are expected to inhibit the adoption of these services.

Competitive Landscape

The home infusion therapy market is made up of over 800 independent companies, indicating a historically low barrier to entry for licensed pharmacies and nursing agencies. Market leaders utilize vertical integration by owning compounding pharmacies, logistics fleets, and nursing pools to protect their profit margins against reimbursement pressures. Additionally, technology differentiation provides a competitive advantage; for example, BrightSpring Health Services increased its infusion and specialty prescriptions by 22% between December 2023 and December 2024 by implementing e-prescribing, telepharmacy, and AI-based therapy monitoring.

Private equity sponsors are driving consolidation in the market by employing roll-up strategies that combine regional players into national or multi-state platforms. These investors provide capital for upgrading pump fleets, enhancing cybersecurity, and improving payer-contact analytics, which increases the operational sophistication of these companies. Device manufacturers, such as Becton Dickinson, recently announced a corporate separation to focus more on medication delivery and advanced monitoring. To counteract pump commoditization, they are bundling software services with analytics dashboards.

Emerging disruptors in the market include specialty pharmacies that are integrating infusion suites to capture lucrative orphan-drug revenues, as well as med-tech startups offering predictive maintenance for infusion pumps. While competitive intensity remains high, larger entities are better positioned to navigate regulatory scrutiny, nursing shortages, and cybersecurity challenges.

Recent Industry Developments

March 2025: The Medicare Payment Advisory Commission recommended payment updates for 2026 that continue to support home health services essential for delivering infusion therapy.

February 2025: Court Square Capital Partners completed a strategic investment in Soleo Health, a national specialty pharmacy and infusion provider that serves over 22,000 patients annually.

February 2025: Becton Dickinson announced plans to spin off its Biosciences and Diagnostic Solutions units, creating a focused med-tech company centered on medication delivery platforms and patient monitoring.

Contact Us:
Company Name: Renub Research
Contact Person: Rajat Gupta
Phone No: (D) +91-120-421-9822 (IND)
Email: rajat@renub.com

About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 15 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.

This release was published on openPR.